---
title: Simplified Competitor Teardown - Abridge
updated: 2026-07-07 11:46 EDT
---

#capstone #ai-internship #neurology #competitor

---

# Abridge — Simplified Competitor Teardown

---

## What Abridge Actually Is

Abridge sits in the room with the doctor and patient, records the conversation, and writes the clinical note. That's it. It's a scribe — a very good one.

The doctor opens the app on their phone, the patient consents verbally, and Abridge generates a structured note (SOAP, H&P, neuro H&P, whatever the specialty needs) with every sentence traceable back to the audio. The note drops into Epic, Cerner, or athena.

Founded 2018 by Dr. Shiv Rao — a cardiologist who left UPMC to build this. Pittsburgh-based. Raised ~$808M, most recently $300M Series E at $5.3B (Feb 2025). Deployed at 300+ health systems including Mayo, Cleveland Clinic, Stanford, UPMC, Emory, Yale, and all six UC medical centers. Only ambient AI scribe with a peer-reviewed JAMA study. Back-to-back Best in KLAS (2025 and 2026).

---

## The Numbers That Matter

**Money:**
- ~$808M raised total
- Series E: $300M at $5.3B (Feb 2025) — just four months after a $250M Series D
- Estimated pricing: $250–$400/provider/month (third-party estimates; Abridge doesn't publish prices)

**Scale:**
- 300+ health systems
- 1M+ encounters processed per week (per whitepaper)
- 28+ languages

**Clinical outcomes (the real numbers):**
- Physician burnout dropped from **51.9% → 38.8%** in 30 days (JAMA Network Open, 263 clinicians across 6 health systems, Oct 2025)
- ~10.8 minutes saved per workday
- 81% of clinicians said documentation got easier; 73% spent less time documenting after hours (KUMC study, 181 clinicians)
- 4.3/5 star rating in English, 4.1/5 Spanish, 4.4/5 Japanese (tens of thousands of ratings, May–Jul 2025)

**Technical benchmarks (internal, from Abridge whitepapers):**
- WER: 12.7% — 24% better than other medical ASR models
- Medical Term Recall: 97%
- Confabulation catch rate: **97%** (vs. GPT-4o at 82% — off-the-shelf models miss ~6× more)

---

## What It Does Well

**The core product is strong:**

1. **Ambient capture** — records the visit, handles patient consent, works on iOS/Android
2. **Multi-speaker separation** — patient, doctor, family members, interpreters all labeled
3. **Linked Evidence** — the trademarked feature: click any sentence in the note, see the exact audio clip and transcript snippet that produced it. This is their main trust-builder with clinicians
4. **Specialty depth** — 30+ specialty templates including neuro, cardiology, primary care, discharge summary
5. **EHR write-back** — drops notes directly into Epic (deepest), Cerner/Oracle, athena via SMART-on-FHIR
6. **Speed** — median note generation dropped from 76 sec (mid-2023) to 38 sec (mid-2024)
7. **Multilingual** — 28+ languages; Spanish, Mandarin, Japanese, Arabic, etc.
8. **No FDA clearance needed** — positioned as documentation software, not clinical decision support. They ship fast

---

## The Real Gaps — Where Abridge Leaves Space

This is the important part. Abridge is dominant in what it does. But here's what it doesn't do:

**Gap 1 — The doctor still walks into the room cold**
Abridge sees the conversation. It does not see the chart. The doctor still has to read the prior visits, the last neurology note, the imaging results from six months ago. No longitudinal synthesis.

**Gap 2 — No pre-visit briefing**
Nothing surfaces what happened in the last three visits, what was ruled out, what the top question is for today. The doctor gets no briefing before the room.

**Gap 3 — No between-visit data**
No wearables. No symptom logs. No Apple Watch seizure data, no StrivePD for Parkinson's, no EpiMonitor epilepsy data. Abridge only knows what happened inside the room.

**Gap 4 — No caregiver channel**
For dementia, stroke recovery, pediatric neurology, ALS — the caregiver is often the primary information source. Abridge has no mechanism for caregivers to contribute. No intake form, no consent flow, no HIPAA-compliant caregiver portal.

**Gap 5 — The patient never sees the note**
There's no patient-facing view. No way for patients to read, correct, or add to what was documented. The note is between the doctor and the system.

**Gap 6 — No structured chronic-disease scoring**
No automatic UPDRS (Parkinson's), no EDSS (MS), no MIDAS (migraine), no seizure calendar tracking. The longitudinal progression of a chronic neurological condition is invisible to Abridge.

---

## The 8-Point Patient Pain Point Score

*(How well does Abridge address the 8 patient pain points from the research corpus?)*

| # | Pain Point | Abridge Covers It? |
|---|---|---|
| 1 | Doctor dismisses symptoms as anxiety | **No** — sees only today's room, not the history |
| 2 | 13-year diagnostic journey | **No** — per-visit note only, no longitudinal summary |
| 3 | 10-minute appointments | **Partial** — saves 10 min/day, not per encounter |
| 4 | Doctor says EEG was "normal" when it isn't | **No** — no ambiguous-result flagging or patient translation |
| 5 | Patients punished for self-advocacy | **No** — patient never sees the note |
| 6 | Doctor doesn't see between-visit data | **No** — only in-room audio |
| 7 | Caregivers are the real info source | **No** — no caregiver role at all |
| 8 | Medical education gaps (referrals, guidelines) | **Partial** — specialty templates help, no guideline alerts |

**Score: 0 full / 2 partial / 6 no. Abridge covers roughly 8% of the patient pain points.**

This is a clean signal. The entire gap maps to one unoccupied layer: **the pre-visit synthesis**.

---

## What This Means For Us

Abridge owns the in-room documentation layer. It is the best-in-class incumbent and is not going away. The switching cost once a health system deploys Abridge — dot-phrase library, EHR integration, clinician habits, JAMA publications as sales collateral — is very high.

The open space is **before the room**. The pre-visit briefing: pulling the chart, the imaging, the wearables, the caregiver intake, the between-visit symptom logs, and synthesizing all of it into one structured briefing the doctor sees before walking in.

Nobody owns that layer. Not Abridge. Not DeepScribe. Not Nuance DAX. Not Suki. Not any of the 16 competitors in the landscape.

**Our wedge: pre-visit synthesis. Caregiver-in-the-loop. Longitudinal chronic-disease tracking.**

The three strongest openings:
- **Dementia / caregivers** — no competitor has a caregiver intake + synthesis layer
- **Epilepsy wearables** — EpiMonitor, Apple Watch seizure data, between-seizure logs
- **Headache / migraine** — longitudinal trigger tracking, MIDAS scoring, pre-visit migraine diary synthesis

---

## The One Nuance Worth Knowing

Abridge's 2026 STAT News article reported scribes save clinicians **under 1 minute per clinical note** in some studies. A separate study (1,800 clinicians, 5 academic medical centers, 2023–2025) found more meaningful savings: 16 minutes per 8-hour shift. Even so — the real value may be less about time savings and more about burnout reduction. The burnout numbers (51.9% → 38.8%) are the most clinically meaningful data point.

---

## Bottom Line

| | |
|---|---|
| **What Abridge is** | Best-in-class ambient scribe, in-room only |
| **What it's not** | Pre-visit synthesis, longitudinal tracker, caregiver tool |
| **Threat to us** | Low — different layer entirely |
| **Opportunity** | Own the pre-visit briefing layer that Abridge doesn't touch |

---

## Key Sources

- [jamanetwork.com/journals/jamanetworkopen/fullarticle/2839542](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2839542) — Olson et al., JAMA Network Open, Oct 2025
- [pmc.ncbi.nlm.nih.gov/articles/PMC11843214/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11843214/) — Tierney et al., KUMC, JAMIA Open, Feb 2025
- [statnews.com/2026/04/01/ai-ambient-scribes-modest-time-savings-clinical-documentation/](https://www.statnews.com/2026/04/01/ai-ambient-scribes-modest-time-savings-clinical-documentation/) — STAT News, Apr 2026
- [news.crunchbase.com/health-wellness-biotech/ai-doctor-note-taking-startup-abridge/](https://news.crunchbase.com/health-wellness-biotech/ai-doctor-note-taking-startup-abridge/) — funding history
- [fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla](https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla) — Series E
- [abridge.com](https://www.abridge.com/) — company homepage
- [[Source - Abridge AI Evaluation Whitepaper]]
- [[Source - Abridge Confabulation Elimination Whitepaper]]
- [[Source - Becker's Abridge Profile]]
- [[Source - Trelis Medical ASR Benchmarks]]

---

*Related: [[Competitor Teardown - Viz.ai]] · [[Competitor Teardown - Ceribell]] · [[Competitor Teardowns - Cross-Competitor Analysis]]*
